# US 2018/0021266 A1 · Buffered Oxygen Therapeutics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021266 A1
- Document ID: US20180021266A1
- Status: Published application
- Kind: A1
- Application number: 15/617,492
- Filed: 2017-06-08
- Published: 2018-01-25
- Earliest claimed: 2011-10-13
- Assignees: NuvOx Pharma LLC
- Applicants: NuvOx Pharma LLC
- Inventors: Evan C. Unger; Edmund R. Marinelli
- Web page: https://patentgrep.com/patent/US20180021266A1

## CPC

- A61K 31/02: Halogenated hydrocarbons
- A61K 9/0026: {Blood substitute; Oxygen transporting formulations; Plasma extender}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/025: carbocyclic
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

An oxygen therapeutic composition, which includes a perfluorocarbon material having a boiling point of about 4 degrees Celsius to about 60 degrees Celsius, a lipid; a viscosity modifier; a buffer.

## Claims

### Claim 1

An oxygen therapeutic composition, comprising:
a perfluorocarbon material having a boiling point of about 4 degrees Celsius to about 60 degrees Celsius;
a lipid;
a viscosity modifier;
a buffer;
wherein:
the buffer stabilizes a pH of the composition at between about 6.5 to about 7.5; and
the composition comprises a viscosity of about 2.0 to about 3.5 mPas.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said lipid comprises a polyethylene glycol (“PEG”) moiety.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the number average molecular weight of said PEG moiety is between about 100 Daltons to about 20,000 Daltons.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the number average molecular weight of said PEG moiety is between about 1,000 Daltons to about 10,000 Daltons.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the number average molecular weight of said PEG moiety is between about 2,000 Daltons to about 5,000 Daltons.

### Claim 6 (depends on 2)

The composition of claim 2, wherein said lipid moiety comprises between about 10 carbons to about 24 carbons in length.

### Claim 7 (depends on 2)

The composition of claim 2, wherein said lipid moiety comprises between about 12 carbons to about 22 carbons in length.

### Claim 8 (depends on 2)

The composition of claim 2, wherein said lipid moiety comprises between about 14 carbons to about 20 carbons in length.

### Claim 9 (depends on 3)

The composition of claim 3, wherein said viscosity modifier comprises sucrose.

### Claim 10 (depends on 9)

The composition of claim 9, wherein said sucrose is present at a level of between about 28 weight percent and about 30 weight percent.

### Claim 11 (depends on 9)

The composition of claim 9, wherein said composition does not comprise fructose.

### Claim 12 (depends on 9)

The composition of claim 9, wherein said composition does not comprise glucose.

### Claim 13 (depends on 2)

The composition of claim 2, wherein said buffer is formed from equal molar parts of (0.005 M) NaH2PO4 and (0.005 M) Na2HPO4.

### Claim 14 (depends on 2)

The composition of claim 2, further comprising dipalmitoylphosphatidylcholine.

### Claim 15 (depends on 14)

The composition of claim 14, further comprising dipalmitoylphosphatidylethanolamine with a covalently linked poly(ethylene glycol) moiety comprising a number average molecular weight of about 5000.

### Claim 16 (depends on 15)

The composition of claim 15, wherein said composition is homogenized to form an emulsion.
